Finance

Beta
Lists
600332:SHA
Guangzhou Baiyunshan Pharmaceutical Holdings Ord Shs A
CN¥21.48
+0.70%
(+0.15) 1D
Jun 5, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600332...
Open
CN¥21.31
High
CN¥21.58
Low
CN¥21.31
Mkt. cap
32.92B
Avg. vol.
9.31M
Volume
5.92M
P/E ratio
11.86
52-wk high
CN¥27.85
52-wk low
CN¥21.19
EPS
CN¥1.81
Shares outstanding
1.41B
No. of employees
27K
Open
CN¥21.31
High
CN¥21.58
Low
CN¥21.31
Mkt. cap
32.92B
Avg. vol.
9.31M
Volume
5.92M
P/E ratio
11.86
52-wk high
CN¥27.85
52-wk low
CN¥21.19
EPS
CN¥1.81
Shares outstanding
1.41B
No. of employees
27K
News stories
From sources across the web
About Guangzhou Baiyunshan Pharmaceutical Holdings Ord Shs A
CEO-
Employees27.1K
FoundedSep 1, 1997
Headquarters-
SectorHealth care provider
Websitegybys.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
19.36B
19.77B
16.05B
23.28B
Cost of goods sold
16.32B
16.58B
14.37B
18.55B
Cost of revenue
16.32B
16.58B
14.37B
18.55B
Research and development expenses
141.57M
158.44M
217.91M
158.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.03B
1.88B
2.21B
2.22B
Operating expense
2.32B
2.05B
2.50B
2.55B
Total operating expenses
18.64B
18.63B
16.87B
21.10B
Operating income
720.14M
1.14B
-820.04M
2.18B
Other non operating income
-29.56M
83.07M
-100.40M
-1.28M
EBT including unusual items
859.43M
1.09B
-494.18M
2.21B
EBT excluding unusual items
720.90M
1.24B
-825.17M
2.21B
Income tax expense
140.96M
271.49M
-156.77M
383.93M
Effective tax rate
16.40%
24.82%
31.72%
17.39%
Other operating expenses
102.35M
-46.93M
164.17M
91.90M
Net income
694.83M
793.91M
-326.94M
1.78B
Net profit margin
3.59%
4.02%
-2.04%
7.66%
Earnings per share
-
-
-
-
Interest and investment income
126.69M
117.54M
187.01M
140.88M
Interest expense
-102.39M
-101.91M
-95.60M
-103.44M
Net interest expenses
24.31M
15.64M
91.41M
37.44M
Depreciation and amortization charges
-
-
-
-
EBITDA
874.88M
1.29B
-660.36M
2.34B
Gain or loss from assets sale
-3.63M
3.63M
-107.74M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer